id | C00000206 |
---|---|
Name | Saligel / Salonil / Salicylic acid / 2-Carboxyphenol / o-Hydroxybenzoic acid |
CAS RN | 69-72-7 |
Standard InChI | InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10) |
Standard InChI (Main Layer) | InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10) |
Phytochemical cluster | No. 81 |
---|---|
KCF-S cluster | No. 817 |
By standard InChI | CHEMBL424 |
---|---|
By standard InChI Main Layer | CHEMBL424 |
By LinkDB | C00805 |
---|
By CAS RN | D020156 |
---|
class name | count |
---|---|
asterids | 6 |
rosids | 4 |
Liliopsida | 2 |
Spermatophyta | 2 |
family name | count |
---|---|
Asteraceae | 2 |
Boraginaceae | 1 |
Rutaceae | 1 |
Colchicaceae | 1 |
Pinaceae | 1 |
Apocynaceae | 1 |
Salicaceae | 1 |
Lamiaceae | 1 |
Brassicaceae | 1 |
Ericaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL424 |
CHEMBL1909136
(2)
|
1 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | CHEMBL424 |
CHEMBL823713
(1)
CHEMBL953279
(1)
CHEMBL2015664 (1) |
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL424 |
CHEMBL1613842
(1)
|
4 / 2 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | CHEMBL424 |
CHEMBL2075389
(2)
|
0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | CHEMBL424 |
CHEMBL1664429
(1)
|
0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL424 |
CHEMBL1909139
(2)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL424 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL424 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL424 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL424 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL424 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL424 |
CHEMBL1909176
(2)
|
0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | CHEMBL424 |
CHEMBL992755
(1)
|
0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | CHEMBL424 |
CHEMBL992754
(1)
|
0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | CHEMBL424 |
CHEMBL992757
(1)
|
0 / 0 |
P22894 | Neutrophil collagenase | M10A | CHEMBL424 |
CHEMBL1664434
(1)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL424 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL424 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL424 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL424 |
CHEMBL1664435
(1)
CHEMBL1909197
(2)
|
2 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL424 |
CHEMBL933690
(1)
CHEMBL991856
(1)
CHEMBL1002070 (1) CHEMBL1002074 (1) CHEMBL1909123 (2) |
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL424 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL424 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL424 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL424 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL424 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL424 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL424 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL424 |
CHEMBL1909093
(2)
|
0 / 0 |
P02768 | Serum albumin | Secreted protein | CHEMBL424 |
CHEMBL702885
(1)
CHEMBL835062
(1)
CHEMBL1805606 (1) CHEMBL1805607 (1) CHEMBL1805608 (1) CHEMBL1805609 (1) |
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL424 |
CHEMBL2076205
(1)
|
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL424 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL424 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL424 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL424 |
CHEMBL1909135
(2)
|
0 / 1 |
P08236 | Beta-glucuronidase | Enzyme | CHEMBL424 |
CHEMBL1071205
(1)
|
1 / 2 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL424 |
CHEMBL1909203
(2)
|
1 / 11 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL424 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL424 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL424 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL424 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL424 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL424 |
CHEMBL1909214
(2)
|
0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | CHEMBL424 |
CHEMBL992756
(1)
CHEMBL1804479
(1)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL424 |
CHEMBL1909175
(2)
|
0 / 0 |
P05067 | Amyloid beta A4 protein | Membrane receptor | CHEMBL424 |
CHEMBL649530
(1)
|
2 / 2 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL424 |
CHEMBL1909096
(2)
|
1 / 1 |
O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | CHEMBL424 |
CHEMBL1070134
(1)
|
0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL424 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL424 |
CHEMBL1909166
(2)
|
1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | CHEMBL424 |
CHEMBL981174
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL424 |
CHEMBL1614458
(2)
|
0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | CHEMBL424 |
CHEMBL992759
(1)
|
1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL424 |
CHEMBL1909133
(2)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL424 |
CHEMBL1738606
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL424 |
CHEMBL2114780
(1)
|
0 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | CHEMBL424 |
CHEMBL2076657
(1)
CHEMBL2076228
(1)
CHEMBL2078139 (1) |
0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | CHEMBL424 |
CHEMBL1743330
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL424 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL424 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL424 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL424 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL424 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL424 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL424 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL424 |
CHEMBL1909104
(2)
|
0 / 0 |
P15121 | Aldose reductase | Enzyme | CHEMBL424 |
CHEMBL642955
(1)
CHEMBL642959
(1)
CHEMBL642961 (1) CHEMBL642962 (1) |
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL424 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL424 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL424 |
CHEMBL1909167
(2)
|
1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | CHEMBL424 |
CHEMBL933689
(1)
CHEMBL991855
(1)
CHEMBL1002069 (1) CHEMBL1002071 (1) |
0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL424 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL424 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL424 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL424 |
CHEMBL1664431
(1)
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL424 |
CHEMBL1909119
(2)
|
0 / 0 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | CHEMBL424 |
CHEMBL2077503
(1)
CHEMBL2077520
(1)
CHEMBL2076041 (1) |
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL424 |
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL424 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL424 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL424 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL424 |
CHEMBL1909109
(2)
|
2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL424 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL424 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL424 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL424 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL424 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL424 |
CHEMBL1909108
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL424 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL424 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL424 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL424 |
CHEMBL1909132
(2)
|
0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | CHEMBL424 |
CHEMBL992758
(1)
|
0 / 1 |
P08253 | 72 kDa type IV collagenase | M10A | CHEMBL424 |
CHEMBL1664432
(1)
|
1 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL424 |
CHEMBL1614038
(2)
|
2 / 2 |
P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | CHEMBL424 |
CHEMBL1908092
(1)
|
0 / 0 |
P36537 | UDP-glucuronosyltransferase 2B10 | Enzyme | CHEMBL424 |
CHEMBL1908089
(1)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL424 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL424 |
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL424 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL424 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL424 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL424 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL424 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL424 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL424 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL424 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL424 |
CHEMBL1909168
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL424 |
CHEMBL1909134
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL424 |
CHEMBL1909138
(2)
|
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL424 |
CHEMBL1909137
(2)
|
0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL424 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL424 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL424 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL424 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL424 |
CHEMBL1909116
(2)
|
1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | CHEMBL424 |
CHEMBL991857
(1)
|
0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL424 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL424 |
CHEMBL1909128
(2)
|
0 / 0 |
P08254 | Stromelysin-1 | M10A | CHEMBL424 |
CHEMBL813241
(1)
CHEMBL1664433
(1)
|
1 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | CHEMBL424 |
CHEMBL991858
(1)
|
1 / 1 |
Q9UHC3 | Acid-sensing ion channel 3 | Unclassified protein | CHEMBL424 |
CHEMBL1629312
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL424 |
CHEMBL1613914
(1)
|
0 / 0 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | CHEMBL424 |
CHEMBL2075518
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D020156 | 1645 |
AKR1C1
2-ALPHA-HSD 20-ALPHA-HSD C9 DD1 DD1/DD2 DDH DDH1 H-37 HAKRC HBAB MBAB |
aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) | Salicylic Acid results in decreased activity of AKR1C1 protein |
decreases activity
|
protein |
19010312
|
D020156 | 1646 |
AKR1C2
AKR1C-pseudo BABP DD DD2 DDH2 HAKRD HBAB MCDR2 SRXY8 |
aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) | Salicylic Acid results in decreased activity of AKR1C2 protein |
decreases activity
|
protein |
19010312
|
D020156 | 1646 |
AKR1C2
AKR1C-pseudo BABP DD DD2 DDH2 HAKRD HBAB MCDR2 SRXY8 |
aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) | Salicylic Acid results in increased expression of AKR1C2 mRNA |
increases expression
|
mRNA |
20491607
|
D020156 | 8644 |
AKR1C3
DD3 DDX HA1753 HAKRB HAKRe HSD17B5 PGFS hluPGFS |
aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | Salicylic Acid results in decreased activity of AKR1C3 protein |
decreases activity
|
protein |
19010312
|
D020156 | 3565 |
IL4
BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
interleukin 4 | Salicylic Acid results in decreased expression of IL4 mRNA |
decreases expression
|
mRNA |
11238116
|
D020156 | 3565 |
IL4
BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
interleukin 4 | Salicylic Acid results in decreased secretion of IL4 protein |
decreases secretion
|
protein |
11238116
|
D020156 | 23764 |
MAFF
U-MAF hMafF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F | Salicylic Acid results in increased expression of MAFF mRNA |
increases expression
|
mRNA |
20491607
|
D020156 | 4489 |
MT1A
MT1 MT1S MTC |
metallothionein 1A | Salicylic Acid results in increased expression of MT1A mRNA |
increases expression
|
mRNA |
20491607
|
D020156 | 55867 |
SLC22A11
OAT4 hOAT4 |
solute carrier family 22 (organic anion/urate transporter), member 11 | Salicylic Acid results in decreased activity of SLC22A11 protein |
decreases activity
|
protein |
12388633
|
D020156 | 55867 |
SLC22A11
OAT4 hOAT4 |
solute carrier family 22 (organic anion/urate transporter), member 11 | SLC22A11 protein results in increased uptake of Salicylic Acid |
increases uptake
|
protein |
12388633
|
D020156 | 9356 |
SLC22A6
HOAT1 OAT1 PAHT ROAT1 |
solute carrier family 22 (organic anion transporter), member 6 | Salicylic Acid results in decreased activity of SLC22A6 protein |
decreases activity
|
protein |
12388633
|
D020156 | 9356 |
SLC22A6
HOAT1 OAT1 PAHT ROAT1 |
solute carrier family 22 (organic anion transporter), member 6 | SLC22A6 protein results in increased uptake of Salicylic Acid |
increases uptake
|
protein |
12388633
|
D020156 | 10864 |
SLC22A7
NLT OAT2 |
solute carrier family 22 (organic anion transporter), member 7 | Salicylic Acid results in decreased activity of SLC22A7 protein |
decreases activity
|
protein |
12388633
|
D020156 | 10864 |
SLC22A7
NLT OAT2 |
solute carrier family 22 (organic anion transporter), member 7 | SLC22A7 protein results in increased uptake of Salicylic Acid |
increases uptake
|
protein |
12388633
|
D020156 | 114571 |
SLC22A9
HOAT4 OAT4 OAT7 UST3H ust3 |
solute carrier family 22 (organic anion transporter), member 9 | Salicylic Acid results in decreased activity of SLC22A9 protein |
decreases activity
|
protein |
12388633
|
D020156 | 114571 |
SLC22A9
HOAT4 OAT4 OAT7 UST3H ust3 |
solute carrier family 22 (organic anion transporter), member 9 | SLC22A9 protein results in increased uptake of Salicylic Acid |
increases uptake
|
protein |
12388633
|
D020156 | 7295 |
TXN
TRDX TRX TRX1 |
thioredoxin | Salicylic Acid results in increased expression of TXN mRNA |
increases expression
|
mRNA |
20491607
|
D020156 | 54575 |
UGT1A10
UDPGT UGT-1J UGT1-10 UGT1.10 UGT1J |
UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | UGT1A10 protein results in increased glucuronidation of Salicylic Acid |
increases glucuronidation
|
protein |
15117964
|
D020156 | 54659 |
UGT1A3
UDPGT UDPGT_1-3 UGT-1C UGT1-03 UGT1.3 UGT1C |
UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | UGT1A3 protein results in increased glucuronidation of Salicylic Acid |
increases glucuronidation
|
protein |
15117964
|
D020156 | 54577 |
UGT1A7
UDPGT UDPGT_1-7 UGT-1G UGT1-07 UGT1.7 UGT1G |
UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | UGT1A7 protein results in increased glucuronidation of Salicylic Acid |
increases glucuronidation
|
protein |
15117964
|
D020156 | 54576 |
UGT1A8
UDPGT UDPGT_1-8 UGT-1H UGT1-08 UGT1.8 UGT1A8S UGT1H |
UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | UGT1A8 protein results in increased glucuronidation of Salicylic Acid |
increases glucuronidation
|
protein |
15117964
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#104300 | Alzheimer disease; ad |
P05067
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#605714 | Cerebral amyloid angiopathy, app-related |
P05067
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#253220 | Mucopolysaccharidosis, type vii; mps7 |
P08236
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00056 | Alzheimer's disease (AD) |
P05067
(related)
|
H01185 | Cerebral amyloid angiopathy (CAA) |
P05067
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00132 | Mucopolysaccharidosis type VII (MPS7) |
P08236
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
P08236
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D001249 | D020156 | Asthma |
marker/mechanism
|
6715990
|
|
D003128 | D020156 | COMA |
marker/mechanism
|
6484774
|
|
D004342 | D020156 | Drug Hypersensitivity |
marker/mechanism
|
6715990
|
|
D034381 | D020156 | Hearing Loss |
therapeutic
|
10418821
|
|
D006685 | D020156 | Hoarseness |
marker/mechanism
|
6715990
|
|
D007819 | D020156 | Laryngeal Edema |
marker/mechanism
|
6715990
|
|
D009668 | D020156 | Nose Diseases |
marker/mechanism
|
6715990
|
|
D049188 | D020156 | Prenatal Injuries |
marker/mechanism
|
4502305
|
|
D012640 | D020156 | Seizures |
marker/mechanism
|
6484774
|
|
D014012 | D020156 | Tinnitus |
marker/mechanism
|
18632935
|
|
D014581 | D020156 | Urticaria |
marker/mechanism
|
6715990
|
|
D014860 | D020156 | Warts |
therapeutic
|
12852385
|